Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 3 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Next-generation microbiological testing in intraabdominal infections with PCR technology.
Langenbecks Arch Surg. 2024 Apr 3;409(1):108. doi: 10.1007/s00423-024-03298-9.
Langenbecks Arch Surg. 2024.
PMID: 38570375
Free PMC article.
In Vitro Experiments on the Effects of GP-2250 on BRAF-Mutated Melanoma Cell Lines and Benign Melanocytes.
Gambichler T, Harnischfeger F, Skrygan M, Majchrzak-Stiller B, Buchholz M, Müller T, Braumann C.
Gambichler T, et al. Among authors: majchrzak stiller b.
Int J Mol Sci. 2023 Oct 19;24(20):15336. doi: 10.3390/ijms242015336.
Int J Mol Sci. 2023.
PMID: 37895015
Free PMC article.
Item in Clipboard
GP-2250, a novel anticancer agent, inhibits the energy metabolism, activates AMP-Kinase and impairs the NF-kB pathway in pancreatic cancer cells.
Majchrzak-Stiller B, Buchholz M, Peters I, Waschestjuk D, Strotmann J, Höhn P, Hahn S, Braumann C, Uhl W, Müller T, Möhler H.
Majchrzak-Stiller B, et al.
J Cell Mol Med. 2023 Jul;27(14):2082-2092. doi: 10.1111/jcmm.17825. Epub 2023 Jun 30.
J Cell Mol Med. 2023.
PMID: 37390227
Free PMC article.
Item in Clipboard
The effect of GP-2250 on cultured virus-negative Merkel cell carcinoma cells: preliminary results.
Gambichler T, Majchrzak-Stiller B, Peters I, Becker JC, Strotmann J, Abu Rached N, Müller T, Uhl W, Buchholz M, Braumann C.
Gambichler T, et al. Among authors: majchrzak stiller b.
J Cancer Res Clin Oncol. 2023 Sep;149(12):10831-10840. doi: 10.1007/s00432-023-04960-3. Epub 2023 Jun 14.
J Cancer Res Clin Oncol. 2023.
PMID: 37311987
Free PMC article.
Item in Clipboard
Substance GP-2250 as a New Therapeutic Agent for Malignant Peritoneal Mesothelioma-A 3-D In Vitro Study.
Baron C, Buchholz M, Majchrzak-Stiller B, Peters I, Fein D, Müller T, Uhl W, Höhn P, Strotmann J, Braumann C.
Baron C, et al. Among authors: majchrzak stiller b.
Int J Mol Sci. 2022 Jun 30;23(13):7293. doi: 10.3390/ijms23137293.
Int J Mol Sci. 2022.
PMID: 35806313
Free PMC article.
Item in Clipboard
New Therapy Options for Neuroendocrine Carcinoma of the Pancreas-The Emergent Substance GP-2250 and Gemcitabine Prove to Be Highly Effective without the Development of Secondary Resistances In Vitro and In Vivo.
Buchholz M, Strotmann J, Majchrzak-Stiller B, Hahn S, Peters I, Horn J, Müller T, Höhn P, Uhl W, Braumann C.
Buchholz M, et al. Among authors: majchrzak stiller b.
Cancers (Basel). 2022 May 29;14(11):2685. doi: 10.3390/cancers14112685.
Cancers (Basel). 2022.
PMID: 35681665
Free PMC article.
Item in Clipboard
Cite
Cite